ABSTRACT Human serum samples are assayed for insulin by an enzyme-linked sandwich immunoassay. Horseradish peroxidase is used as an enzyme label for antibody, and enzyme activity is measured by means of the fluorogenic substrate, p-hydroxyphenylacetic acid. The product is detected by excitation of fluorescence with the 325-nm line of a continuous-wave helium/cadmium ion laser on line with reverse-phase high-pressure liquid chromatography. The incubation period is 90 min and the limit of detection of insulin.is 30 pM, corresponding to 5 microunits/ml. This method correlates highly with radioimmunoassay, with coefficient of correlation r = 0.95.
Since its development in the late nineteen fifties by Yalow, Berson, and their colleagues, radioimmunoassay (RIA) has proven to be a powerful tool for the analysis of a broad spectrum of substances of biologic interest (1) . Despite its advantages of high sensitivity and specificity, there are a number of drawbacks associated with this technique. These include difficulties in storage, handling, and disposal of the radioisotopic tag and its inherently limited shelf life. As a result, a number of alternative approaches to RIA have been considered. A notable success has been in the development of enzyme immunoassay, in which an enzyme replaces the radioisotopic label, and label content is determined by measuring enzyme activity (2) .
The sensitivity and rapidity of enzyme immunoassays can be limited by the sensitivity of the method used to determine enzyme activity. Typically one measures activity by means of a substrate, S, which is converted upon enzyme catalysis to a product, P, whose spectroscopic properties differ from those of S: enzyme label S P
In the presence of excess S, the amount of P formed is proportional to the amount of enzyme label present and to the duration of enzyme-catalysis. Thus, if a more sensitive method for product quantitation is employed, it should prove possible to detect lower levels of enzyme label and to shorten the duration of the enzyme catalysis step.of the assay.
Commonly, colorimetric or fluorimetric methods are used to measure enzyme activity. Work in our laboratory has demonstrated that the use of a laser as a fluorescence excitation source makes possible the detection of enzyme reaction products at much lower levels than can be detected using colorimetric or conventional fluorimetric techniques (3) . We report here results of a study wherein laser fluorimetric methods are applied to enzyme immunoassay.
Evaluation of a commercial sandwich enzyme immunoassay for insulin has been reported by Yoshioka es aL (4) . In this imethod horseradish peroxidase (HRPase) serves as the antibody label, and enzyme activity is measured by absorbance through a chromogenic substrate. Our strategy is to combine this enzyme immunoassay forinsulin with laser fluorimetric detection of an enzyme reaction product and, thereby, reduce the time requirements of the assay.
There are a number of fluorogenic substrates for HRPase (6) . In this work, we use the nonfluorescent. substrate, p-hydroxyphenylacetic acid (HPA), which in the presence of HRPase and H202 is converted into the fluorescent product 6,-6'-dihydroxy-(1, 1'-biphenyl)-3,3'-diacetic acid (DBDA) as shown below (7) fluorimetry in conjunction with reverse-phase high-pressure liquid chromatography (HPLC), we demonstrate that the measurement of insulin in human serum can be performed significantly more rapidly than by existing methods.
MATERIALS AND METHODS Detection of DBDA. Fig. 1 shows a schematic of the experimental apparatus, which is a modification of a laser fluorimeter previously described (8) . To optimize detection.of DBDA, which fluoresces most intensely under alkaline conditions, an alkalinization scheme is used after chromatography. The eluant from the HPLC column exits into a stainless steel tee connector (low dead volume). Into another part of the tee is pumped 0.075 M NaOH. The effluent passes from the tee to a mixing coil and then exits into the flowing droplet detector through a low deadvolume union.
The 325-nm output (2 mW) of a continuous-wave feedbackstabilized helium/cadmium ion laser (model 4050 UV, Liconix) is focused into the droplet by lens L1. Plasma superradiance is removed by an interference filter (Corion) centered around the laser line. The droplet is imaged onto the cathode of the photomultiplier (Q4249B, Centronic) by lens L2, L3, and the aperture. The spectral region between 410 nm and 490 nm is isolated by the liquid filters F1 (NaNO2, 133 g/l) and F2 (CuSO4, saturated solution). In this way Rayleigh and Raman scattering from the solvent are largely suppressed (3) . The output of the photomultiplier is displayed on a stripchart recorder that has a 0.5-sec time constant.
All chromatographic equipment was obtained from Waters Materials. Methanol and acetic acid were reagent grade and were distilled before use. Water was deionized and distilled. HPA was obtained from Aldrich and purified by sublimation and reverse-phase medium-pressure liquid chromatography (2x) with a Lobar RP8 (EM Associates, Elmsford, NY) column and methanol/water (acidified with acetic acid to pH 2.5), 70:30 (vol/vol), as elution solvent. HRPase (250 units/mg) was obtained from Boehringer Mannheim. The reagents for immunoassay (Insulotec Kit) were obtained from Mochida Pharmaceutical, Tokyo, Japan. These included solid phase antibody, which consisted of a plastic disc (1-cm diameter, 0. Immunoassay. The procedure was adapted from that described previously (4) . To initiate the first reaction, a disc was added to each insulin-containing sample (0.1 ml of serum plus 0.3 ml of assay buffer). After 1 hr at 25°C, 0.1 ml of HRPaselabeled antibody solution was added to each tube. This second reaction proceeded for 15 min at 25°C and was halted by the addition of 5 ml of a solution of Tween 20 surfactant. Fluid was withdrawn by aspiration. This washing procedure was repeated three additional times (total, 4 x 5 ml). Two hundred microliters of HPA solution (12 mM, prepared as described above) and 200 
RESULTS
Limits of Detection for HRPase. Fig. 2 shows a sample chromatogram. One peak, which corresponds to DBDA, is present. When DBDA peak height was plotted against enzyme concentration in the reaction mixture, the relation was found to be linear over the range 1-100 pM. The limit of detection for HRPase was 1 pM. This limit is set by the condition that the peak heightto-noise ratio is 2 for the sample containing the minimum concentration.
Immunoassay. Fig. 3 shows two chromatograms from immunoassay samples. Each is identical in form to the one shown in Fig. 2 . The peak height-to-noise ratio is -100. Fig. 3A shows a sample that contained no insulin. The peak represents enzyme activity from nonspecifically bound HRPase-labeled antibody. Fig. 3B shows a sample that contained 20 microunits (120 pmol) of insulin per ml. The DBDA peak is larger than that in Fig.  3A , as expected. Fig. 4 shows the standard curve for insulin immunoassay obtained under the experimental conditions described above. DBDA peak height is plotted against insulin concentration. The limit of detection for insulin is 5 microunits/ml (30 pM). This limit corresponds to the condition h -hb = 2arb where h is the mean DBDA peak height for a series of samples of a given insulin concentration, o, is the standard deviation in peak height measurements, and the subscript b denotes blank samples (i.e., samples devoid of insulin).
When colorimetric methods are employed, the enzyme immunoassay requires (at a minimum) 60 min for each of the three incubations (4, 5)-a total of 180 min. The effect of incubation time on the sensitivity of the immunoassay with laser fluorimetric detection was examined. When the duration of each of the latter two incubations was decreased from 1 hr to 15 min, the initial slope of the standard curve, (hence, the sensitivity) remained the same. When the duration of the first incubation step was shortened from 1 hr to 30 min, the initial slope decreased by a factor of 1.4 . This corresponded to a detection limit for insulin of 7 microunits/ml. When the duration of the first incubation step was increased from I to 2 hr. no change in the initial value of the slope was observed. 
DISCUSSION
This report describes a successful measurement of insulin in serum by an immunoassay that employs laser fluorimetry. We have reported (8) the sensitive detection of insulin in aqueous buffers. In that work, a fluorescent antigen label was employed, and bound and free insulin were separated on-line by gel filtration HPLC prior to laser fluorimetric detection of the chro-* The existence of a nonzero intercept is quite common and represents the difference in response of the two immunoassays. In the present method, it does not result from failure to correct for background enzyme activity. matographic eluant. Measurements of insulin in human serum were seriously hampered by interfering fluorescent components.
In subsequent work (9) we used, in analogy to Kato et al. (10) , the enzyme ,B-galactosidase as a label for insulin. In this case, bound and free insulin were separated by utilizing a solid-phase antibody. Enzyme activity was detected by means of a fluorogenic substrate and laser fluorimetric detection of its product.
Our limit of detection in the assay buffer was a factor of five lower than that of Kato et at (10) (12) reported encountering a similar difficulty in their experience with f3-galactosidase as an enzyme label.
The limit of insulin detection in the present work, 5 microunits/ml (30 pM), is comparable to that of RIA (13) . Moreover, the correlation with RIA measurements is quite good. In work by Yoshioka et aL (4), 216 serum samples were analyzed with the same immunoassay reagents we used. They reported a high degree of correlation with RIA; the data fit a line of the form y = 1. 172x -4.960, with a coefficient of correlation equal to 0.938. We have replaced the chromogenic substrate with a fluorogenic substitute, and we have verified that the correlation is essentially unaffected by this substitution.
Laser fluorimetry makes possible the detection of the enzyme reaction product DBDA with a high degree of sensitivity.
As a result, the immunoassay may be carried out with significant gains in rapidity. This work represents a significant improvement in speed of immunoassay capable of detecting insulin at the 5 microunits/ml level. The total incubation time, 90 min, is at least a factor of two shorter than that of the method of Yoshioka et aL (4) which uses the same immunoassay reagents but employs chromogenic detection; moreover, it is shorter than that of commercially available insulin RIAs of comparable sensitivity. § In addition, our method displays the potential for further gains in sensitivity and speed of analysis.
Because this method is a sandwich immunoassay, one need not allow the incubation steps to reach a state of near equilibrium as one would in competitive-binding assays. At short incubation times, the concentration of product is linearly proportional to both the original concentration of insulin and the product of all three incubation times (9) . In principle, then, this enzyme immunoassay may be carried out in some arbitrarily short time and at some arbitrarily high sensitivity for insulin, both to be determined by the sensitivity with which product can be detected. At present, however, the assay is not limited by our ability to detect DBDA; the signal/noise ratio on our chromatograms is at least 100. The major constraint in both the sensitivity and rapidity of our assay is the background activity caused by nonspecific binding of HRPase-labeled material to the solid phase.
In order to attain the full potential of the method, this nonspecific binding must be decreased. Preliminary experiments indicate that the background activity may be substantially reduced by reagent pretreatment and simple modifications of the assay protocol. Purification of the HRPase-labeled antibody, [for example by affinity chromatography (14, 15) ] may further diminish this unwanted effect. The use of high-affinity monoclonal antibodies and modifications of the solid phase are other promising routes.
In conclusion, this work demonstrates that laser fluorimetry may be successfully incorporated into an enzyme immunoassay method. The resulting technique is clinically applicable, and § Commercial insulin RIA kits typically call for 3 
